Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma
Hepatobiliary Surg Nutr
.
2023 Apr 10;12(2):248-251.
doi: 10.21037/hbsn-23-91.
Epub 2023 Mar 27.
Author
Philippe Merle
1
Affiliation
1
Hepatology Unit, University Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France.
PMID:
37124689
PMCID:
PMC10129889
DOI:
10.21037/hbsn-23-91
No abstract available
Keywords:
Hepatocellular carcinoma (HCC); lenvatinib; treatment.
Publication types
Editorial
Comment